Centers for Disease Control (CDC), and almost half of these patients were known to have died. Approximately 94% of reported cases can be classified into one of four groups: homosexual or bisexual men, intravenous drug users, persons born in Haiti, and men with hemophilia. Although homosexual and bisexual (gay) men account for more of the reported cases than any other group, attempts to estimate the incidence of the syndrome in gay men have been hampered by the lack of accurate denominator data. For that reason, census data on single (nevermarried) men aged 15 years ·or older were used in a recent study to approximate the number of gay men in various urban populations (2) .
Physicians have reported seeing gay men who do not have the life-threatening illnesses included in the surveil· lance definition for the acquired immunodeficiency syn· dromc yet have conditions that appear to be related. Such conditions include generalized lymphadenopathy, oral candidiasis, chronic fever, diarrhea, or weight loss, and hematologic abnormalities (3) (4) (5) (6) (7) (8) . Although these condi· lions are believed to be commoner than the syndrome, the frequency of their occurrence relative to the syndrome is poorly defined.
Recent evidence has indicated that a retrovirus, which has been given several names including lymphadcnopa· thy-associated virus (LAY) and human T·lymphotropic virus, type Ill (HTLV-111), is the cause of the acquired immunodeficiency syndrome (9, 10) . Serologic surveys have shown that many asymptomatic persons in groups at increased risk for the syndrome have been infected with this virus ( 11-13). However, data on the incidence of HTLV-111/LA V infections in risk groups and the out· come in infected persons arc limited.
The San Francisco Health Department and CDC undertook a collaborative study of a cohort of homosexual and bisexual male clinic patients followed for up to 6 years. Specifically, we studied the incidence of the acquired immunodeficiency syndrome in the cohort, the prevalence of the syndrome and related conditions in a representative sample of cohort members, the incidence of HTLV -III/LAV infections in the sample, and the outcome in persons infected with the virus.
Methods
Between 1978 and 1980, a cohort of approximately 687S ho· mosexual and bisexual men treated for sexually transmitted diseases at the San Francisco City Clinic were enrolled in studies of the prevalence, incidence, and prevention of hepatitis B virus infections ( 14, IS) . At the time of enrollment, basic demographic data and a blood specimen were obtained from each participant. Sera were frozen at -20° C and stored at the coc.
To find the prevalence of the acquired immunodeficiency syndrome in the cohort, the San Francisco Health Department ascertained which members of the cohort had been reported as having the syndrome in San Francisco. No formal procedures were available to determine if patients who were reported to other health departments were cohort members. However, when the Health Department learned that a cohort member had had the diagnosis in another city, that information was verified with the health department of that city.
In 1984, wc attempted to enroll a representative sample of men in the cohort, as well as all other cohort members with the syndrome not included in the sample, in a follow-up study. The sample had two components: The first component was a SO% random sample of 833 men admitted consecutively from January through May 1978 into a study of the prevalence of hepatitis B virus infections. The second component was a 6% random sample of the 6042 men screened from June 1978 through December 1980 for markers of hepatitis B virus infection.
Cohort members selected for follow-up were invited to participate in a study of the acquired.immunodeficiency syndrome. After written informed consent was obtained, participants were interviewed and examined for signs of the syndrome or related conditions. Blood specimens were also obtained. Conditions that were considered to be possibly related td the syndrome were defined as follows:
Generalized lymphadenopathy-palpable nodes of at least I cm in diameter in two or more extrainguinal sites, not more than one of which was cervical.
Other signs or symptoms suggesting prodromal illness-fever or diarrhea lasting at least 2 weeks or weight loss of at least 4.5 kg in the last 4 months; oral candidiasis on examination.
Hematologic abnormalities-hcmatocrit less than 40%, ab· solute lymphocyte count less than 1500/mml, or absolute neutrophil count less than 1200/mml. Serum samples from the participant's initial blood sp<:cimen, collected between 1978 and 1980, and his follow-up specimen, collected in 1984, were tested for antibodies to HTLV-111/LAV by an enzyme-linked immunosorbent assay (ELISA) (GET· CHEI.L JP, KALYANARAMAN were excluded from further analysis. Follow-up blood specimens were also used for a complete blood count.
Results of the ELISA and dates of collection for the earliest and most recent serum specimens were matched by patient number and added to the existing database. Data on members of the SO% and 6% samples were then cross-tabulated by year of specimen collection, health status when examined, and ELl-SA results. Proportions of interest were compared by the stan· dard chi-squared formula with corrections for continuity. Binomial confidence intervals were obtained from published tables ( 16) .
Results
Of the 6875 cohort members, 166 (2.4%) had been reported to have the acquired immunodeficiency syndrome by 31 December 1984. The cumulative incidence of the syndrome in men over age 35 at entry into the cohort ( 4.8%) was significantly higher than the incidence in younger men (2.2%) (p=O.OI). Of the 166 patients with the syndrome, 147 (88.6%) lived in the San Eighty-six (51.8%) of the 166 reported patients in the cohort were known to have died. Forty-one of these deaths occurred during 1984; mortality attributable to the syndrome in 1984 was 600 per 100 000. In the followup sample of cohort members, 22 men were known to have died. Twelve of these deaths were attributed to the syndrome. Other causes of death included chronic hepa· titis (3 men), suicide (3 men), immunoblastic sarcoma ( 1 man), pulmonary embolism ( 1 man), automobile accident (I man), and unknown (1 man). Of the 166 patients, Ill (66.9%) had serum specimens available from 1978 to 1980; 24 (21.6%) of these were positive for HTLV-III/LAV antibody shown by ELISA. At the time these specimens were collected, none of these 24 men had the syndrome. The median interval between specimen collection and diagnosis for these men was 43 months (range, 17 to 60 months).
or the 78S men included in the representative sample, 492 (62.7%) participated in the follow-up study. Rea· sons for nonparticipation included: inability to locate (23.3%), inability to participate ( 1.3% ), refusal to par· ticipate (9.7%), death from causes other than the ac· quired immunodeficiency syndrome (1.3%}, and enroll· mcnt pending ( 1.8%). Because nonparticipants did not give permission for serologic testing of the serum samples obtained from them on entry to the cohort, they were omitted from further analysis.
Overall, 28.S% of the men sampled either had the syn· drome or what may be related conditions (Table I) . For each man in the sample with the syndrome, there were 7.S with lymphadenopathy, l.l with other signs or symp· toms suggesting the prodrome of the syndrome, and 0.8 . with hematologic abnormalities. In addition to the 13 men who had the syndrome at the time of examination, 14 more men from the sample were diagnosed with the syndrome by the end of 1984. Findings in men from the SO% and 6% samples were similar, with the exception of generalized lymphadenopathy, which was present signifi· cantly more often in members of the 50% sample (p=0.004).
The epidemic of the acquired immunodeficiency syn· drome in the sample of cohort members was preceded by an epidemic of HTLV-Ill/LAV infection (Figure 2) . From 1978 to 1984, the prevalence of antibodies to HTLV-III/LA V in serum specimens collected from men in the sample increased from 4.5% in 1978 to 67.4% in 1984 (Table 2) . In 1984, rates of seropositivity were simi· lar for members of the SO% sample (67.8% seropositive) and the 6% sample (66.7% seropositive). At the time of follow-up specimen collection, the rate of seropositivity was significantly higher for persons with the syndrome or LIT.001.1 062 related conditions (91.9%) than for persons who appeared to be well (S7.7%)(p < 0.001 ). Among the men who were seropositive on follow-up specimens, 3.4% had the syndrome and 3S.2% had related conditions. Paired scrum specimens were available for 397 of the men in the sample. Of the 360 men who were seronegative on their initial specimen, 239 (66.4%) were seropos· itivc on their follow-up specimen. Of the men who scro· converted, 40.6% developed the syndrome or related conditions as compared with 8.4% of those who did not seroconvcrt (relative risk, 4.8). The proportion of men who seroconverted was significantly higher for those who developed the syndrome or related conditions (90.7%) than for those who did not (S6.6%)(p < 0.001).
Thirty-one men from the sample who were initially seropositive entered the follow-up study. Of these 31 men, 2 (6.4%; 95% confidence interval, 0.8% to 21.4%) had developed the syndrome, and 8 (2S.8%; 95% conft· de nee interval, 1 1.9% to 44.6%) had developed related conditions over a median follow-up period of 61 months (range, 41 to 76 months). Outcomes in members of the SO% and 6% samples were not significantly different (p=0.8S).
Discussion
The acquired immunodeficiency syndrome is now the major health problem for gay men in San Francisco, particularly those who are members of the City Clinic eo· hort. Over 2% of men in the cohort arc reported to have the syndrome. Because cohort members who develop the syndrome in other cities may not be known to the San Francisco Health Department, this proportion is a minimum estimate. Another 21% of a representative sample of cohort members had generalized lymphadenopathy, a condition reported to progress to the acquired immunodeficiency syndrome in up to 20% of cases (3, 4, 6) . Furthermore, men who entered the cohort in early 1978 (SO% sample) were· significantly more likely to have de· vcloped lymphadenopathy than those who entered later Supplied by The British Library -"The world's knowledge"
LIT.001.1 063 (6% sample); suggesting that lymphadenopathy may be associated with a longer duration of infection. Mortality attributable to the syndrome among cohort members in 1984 (600 per 100 000) substantially exceeded that attributable to all causes of death among white m'en in the United States between ages 25 and 34 years ( 157 per lOO 000) and between ages 35 and 44 years (238 per 100000) in 1982 (17) .
Because HTL V -Ill/LA V appears to be sexually transmissible, it is likely that cohort members, men enlisted from a sexually transmitted diseases clinic, arc at a higher risk for the acquired immunodeficiency syndrome than other gay men in San Francisco. However, the proportion of all patients in San Francisco with the syndrome that are from the cohort has been slowly decreasing. In part, this trend may reflect the spread ofHTLV-111/LAV infections into populations of gay men who have fewer sexual partners than men .in the cohort. Additionally, most cohort members have now been exposed to the virus, and the rate of the syndrome in those exposed may be stabilizing.
Data from both this study and studies of transfusionassociated acquired immunodeficiency syndrome indicate that the incubation period of th'e syndrome is long. In 18 patients with the transfusion-associated syndrome, the median time between transfusion and diagnosis was 28 months ( 18) . In 24 men from the cohort study, the median time between collection of a serum that, in retrospect, had antibodies to HTLV-IJI/LAV and diagnosis of the syndrome was 43 months. Because these 24 men were seropositive on their initial serum specimen, it is likely that many of them had been infected months before the specimen was collected. Thus, their true incubation periods must be even longer. Several recent reports have described the development of the acquired immunodeficiency syndrome in gay men with serologic evidence of HTL V -Ill/LA V infections. Melbye and associates ( 19) found that of 22 seropositive volunteers from a gay organization in Denmark, 2 developed the syndrome over a 14-month observation period. Gocdert and coworkers (20) followed 35 seropositive homosexual male residents of New York City for 2 years and found that 5 developed the ~yndrome, an incidence of 6.9% per year. Compared with these studies, we found that a similar proportion of seropositive men developed the syndrome,· but over a considerably longer follow-up period. In part, differences in outcome could be the result of differences in the populations studied. For example, Goedcrt and coworkers (20) studied patients who visited the private office of an internist in Manhattan in mid-1982. When enrolled, approximately one third of the men had lymphadenopathy, which was significantly associated with HTLV-111 infection at follow-up. On the other hand, City Clinic cohort patients were men who visited a sexually transmitted diseases clinic between 1978 and 1980. Although these men were not examined specifically for conditions that could, in retrospect, be related to the acquired immunodeficiency syndrome, it is unlikely that many were affected.
We can also examine the risk of the syndrome in another way. During the time when 2.4% of the 6875 men in the cohort had been diagnosed with the syndrome, 67% of the 435 men in the follow-up sample developed serologic eviaencc of HTLV-111/LAV infection. If the sample is representative of the entire cohort, we can estimate that approximately 3.6% of the infected men had developed the syndrome by January 1985.
The findings from either the City Clinic sample or other study samples must be applied to larger populations with caution. Nonetheless, these results can be used to approximate the magnitude of the problem created by HTLV-111/LAV infections. As an example, for each per-. son in the cohort sample with the syndrome, approximately 30 had serologic evidence of past or present infection with the virus. Thus, the 8000 reported cases of the syndrome in the United States could indicate that about 240 000 Americans have already been infected with liTLV-111/LA V. An appreciable proportion of seropositive persons will develop the syndrome or related conditions after a prolonged incubation period. Thus, even if all transmission of the virus were to stop immediately, the acquired immunodeficiency syndrome would continue to be a major public health problem for the foreseeable future.
